ArticleFrontiers in oncology2021

The Novel Methylation Biomarker SCARA5 Sensitizes Cancer Cells to DNA Damage Chemotherapy Drugs in NSCLC.

Qi Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.